Processa Pharmaceuticals (PCSA) Preferred Dividend Payments (2012 - 2014)
Processa Pharmaceuticals' (PCSA) quarterly Preferred Dividend Payments came in at $26832.0 in Q3 2014, down 87.45% YoY from $213760.0 in Q3 2013, and down 56.11% on a QoQ basis from $61135.0 in Q2 2014.
Processa Pharmaceuticals (PCSA) Preferred Dividend Payments (2012 - 2014) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 3 years of Preferred Dividend Payments data on file, last reported at $26832.0 in Q3 2014.
- Quarterly Preferred Dividend Payments fell 87.45% year-over-year to $26832.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was -$90779.0 (down 119.96% YoY) and the FY2013 annual result came in at $21302.0, down 93.53% from the prior year.
- Preferred Dividend Payments fell to $26832.0 in Q3 2014, from $61135.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $213760.0 in Q3 2013 to a low of -$217294.0 in Q4 2013.
- A 3-year average of $52326.3 and a median of $65376.0 in 2012 frame the typical range for Preferred Dividend Payments.
- The widest YoY moves for Preferred Dividend Payments: up 138.29% in 2013, down 316.79% in 2013.
- Tracing PCSA's Preferred Dividend Payments over 3 years: stood at $100231.0 in 2012, then sank by 316.79% to -$217294.0 in 2013, then jumped by 112.35% to $26832.0 in 2014.
- The last three Preferred Dividend Payments figures came in at $26832.0 (Q3 2014), $61135.0 (Q2 2014), and $38548.0 (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 26,832.00 |
| Jun 30, 2014 | 61,135.00 |
| Mar 31, 2014 | 38,548.00 |
| Dec 31, 2013 | -217,294.00 |
| Sep 30, 2013 | 213,760.00 |
| Jun 30, 2013 | 41,787.00 |
| Mar 31, 2013 | 98,942.00 |
| Dec 31, 2012 | 100,231.00 |
| Sep 30, 2012 | 89,705.00 |
| Jun 30, 2012 | 69,617.00 |